The severe bone phenotype in microphthalmia (mi) mutant mice indicates that the helix-loop-helix (HLH)-zipper transcription factor encoded by the microphthalmia (Mi) gene has a significant role in the terminal differentiation of multi-nucleated osteoclasts. In addition to providing a very interesting system to study developmentally regulated gene expression in a mammalian system, studying the Mi gene may have direct applications to significant human diseases. In particular, osteoporosis in post-menopausal women and the osteolytic bone destruction and hypercalcemia that occurs in patients with multiple myeloma are examples of clinical conditions where this research may have potential impact. As the knowledge concerning transcriptional regulation and signal transduction increases at exponential rates, new pharmacological targets and strategies for interfering selectively with processes that contribute to human disease become possible. The biology of the Mi locus suggests that the product encoded by this gene might provide such opportunities for the treatment of human bone disease. The long term goal of this application is to determine, at the molecular level, the function of the Mi protein in normal osteoclast biology.
The specific aims of this proposal are: 1. To identify and characterize cis-elements in identified target genes regulated by the Mi protein in the osteoclast cell lineages. 2. To identify the trans-requirements of Mi action in osteoclasts, both through structure function analysis of the Mi gene, but also by identifying osteoclast-specific partners for Mi action. 3. To determine how the Mi product is negatively regulated by CSF-1/c-fms tyrosine kinase signaling pathways in myeloid cell lines and to determine if this regulation occurs in the osteoclast. These studies will be performed in three experimental systems: heterologous cell lines, primary osteoclast-like cells cultured in vitro, and in vivo in mouse transgenic and genetic models. Such information will suggest strategies to specifically interrupt Mi function in the osteoclast.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR044719-02
Application #
2899922
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Sharrock, William J
Project Start
1998-04-01
Project End
2002-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Ohio State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Hawley, Catherine A; Rojo, Rocio; Raper, Anna et al. (2018) Csf1r-mApple Transgene Expression and Ligand Binding In Vivo Reveal Dynamics of CSF1R Expression within the Mononuclear Phagocyte System. J Immunol 200:2209-2223
Peterson, Jennifer M; Wang, David J; Shettigar, Vikram et al. (2018) NF-?B inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model. Nat Commun 9:3431
Carey, Heather A; Hildreth 3rd, Blake E; Geisler, Jennifer A et al. (2018) Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation. Bone Res 6:8
Carey, Heather A; Bronisz, Agnieszka; Cabrera, Jennifer et al. (2016) Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant. J Cell Physiol 231:630-40
Bronisz, Agnieszka; Carey, Heather A; Godlewski, Jakub et al. (2014) The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF). J Biol Chem 289:326-34
Young, Nicholas A; Friedman, Alexandra K; Kaffenberger, Benjamin et al. (2013) Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol Immunol 54:23-31
Sharma, Sudarshana M; Sif, Said; Ostrowski, Michael C et al. (2009) Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice. J Cell Physiol 220:230-7
Sharma, Sudarshana M; Hu, Rong; Bronisz, Agnieszka et al. (2006) Genetics and genomics of osteoclast differentiation: integrating cell signaling pathways and gene networks. Crit Rev Eukaryot Gene Expr 16:253-77
So, Hongseob; Rho, Jaerang; Jeong, Daewon et al. (2003) Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem 278:24209-16
Mansky, Kim C; Sulzbacher, Sabine; Purdom, Georgia et al. (2002) The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter. J Leukoc Biol 71:304-10

Showing the most recent 10 out of 14 publications